All Research
    PAPER GDF15-Cohort Study

    Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: a prospective study

    In approximately 4,100 individuals without cardiovascular disease followed about 20 years (Malmo), GDF-15 improved prediction of all-cause mortality beyond hs-CRP and NT-proBNP; associations with specific cardiovascular endpoints were weaker.

    Evidence

    7/10

    Moderate Evidence

    Sample

    —

    subjects

    Duration

    —

    study period

    Journal

    American Heart Journal

    02

    Key Findings

    1. 01

      GDF-15 improved all-cause mortality prediction beyond hs-CRP and NT-proBNP

    2. 02

      Weaker/attenuated associations with specific cardiovascular endpoints

    03

    Structured Methods

    Study Design
    Cohort Study
    Sample Size
    Not reported
    Study Duration
    Not reported
    Methodology
    Not reported
    Limitations
    Not reported
    04

    Citations & References

    Cite this paper

    Unknown authors (n.d.). Growth differentiation factor-15 is a biomarker for all-cause mortality but less evident for cardiovascular outcomes: a prospective study. American Heart Journal.

    PubMed

    33421373

    Source

    Publisher

    Journal

    American Heart Journal

    05

    Indexing

    Topics

    mortalitybiological aging

    Biomarkers

    GDF-15
    PHS
    671
    / 1000
    T3
    Longevity Operator

    Sample member

    Longevity Operator

    The Peak Human Score · PHS v1

    One number for your longevity journey.

    FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.

    • Metabolic
    • Hormonal
    • Cardiovascular
    • Brain / Cognitive
    • Sleep
    • Musculoskeletal
    • Gut
    • Immunity / Inflammation